News

Orlance Inc. Awarded NIH SBIR Grant for Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma

SEATTLE, Nov. 28, 2023 /PRNewswire/ — Orlance, Inc., a Seattle biotech developing next-generation DNA and RNA vaccines and therapeutics, has been awarded a National Institutes of Health (NIH) Phase I Small Business Innovation Research (SBIR) […]

News

Orlance Inc. Awarded Pivotal $3M NIH SBIR Grant for Advancing MACH-1™ Needle-Free, Powdered Universal Influenza Vaccine to the Clinic

SEATTLE, Nov. 28, 2023 /PRNewswire/ — Orlance, Inc., a Seattle biotech developing next-generation DNA and RNA vaccines and therapeutics, has been awarded a three-year $3M National Institutes of Health (NIH) Phase II Small Business Innovation […]

News

Banjo Health and Opala Announce Strategic Partnership to Revolutionize Prior Authorization with AI and Interoperability

Health plans who implement CMS requirements before 2026 mandate will save millions by implementing now WASHINGTON and SEATTLE, Nov. 28, 2023 /PRNewswire/ — Banjo Health, a leader in generative AI-powered prior authorization software, and Opala, […]